查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1564957

高解析度熔化分析的全球市场

High-Resolution Melting Analysis
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球高解析度熔化分析市场预计将达到 4.192 亿美元

高解析度熔化分析的全球市场预计 2023 年为 3.438 亿美元，预计到 2030 年将达到 4.192 亿美元，2023 年至 2030 年复合年增长率为 2.9%。其他应用程式是本报告分析的细分市场之一，预计复合年增长率为 1.4%，到分析期结束时将达到 3,110 万美元。在分析期间，表观遗传学应用领域的复合年增长率预计为 1.7%。

美国市场预估为9,250万美元，中国预期复合年增长率为2.7%

预计 2023 年美国高解析度熔化分析市场规模将达到 9,250 万美元。中国作为世界第二大经济体，预计到 2030 年市场规模将达到 6,710 万美元，2023-2030 年分析期间复合年增长率为 2.7%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 2.7% 和 2.3%。在欧洲，德国的复合年增长率预计为 3.2%。

全球高解析度熔化分析市场－主要趋势与驱动因素总结

高解析度熔解分析 (HRM) 是现代分子诊断中快速且准确的基因组分析的关键吗？

高解析度熔解 (HRM) 分析正在彻底改变分子诊断和基因研究，但为什么这种方法在现代实验室中如此重要？ HRM 是一种聚合酵素链锁反应(PCR) 后分析技术，用于识别 DNA 中的遗传变异，例如单核苷酸多态性 (SNP)、突变和甲基化差异。透过监测双链DNA 解离成单链时的精确熔解行为，HRM 提供了一种快速、高通量的方法来检测 DNA 序列的细微变化。它广泛应用于医学诊断、基因研究、表观遗传学研究和病原体检测，为繁琐的定序方法提供了一种经济、准确、高效的替代方案。

HRM 的吸引力在于它可以以最少的设置和成本提供详细的基因组资讯。 HRM 速度快、可扩展且可自动化，非常适合需要快速结果的应用，例如临床环境、癌症研究和农业生物技术。 HRM 具有高度敏感性，甚至可以检测最轻微的基因突变，这使其可用于识别致病突变、监测抗药性和检验遗传标记。随着基因组研究和精准医学的不断扩展，HRM 在推动分子诊断和个人化医疗保健方面发挥越来越重要的作用。

高解析度熔化分析技术如何进步

技术进步显着提高了高解析度熔解分析的灵敏度、准确性和效率，使其成为遗传和诊断应用中更易于使用和更强大的工具。主要发展之一是开发了具有高解析度光学和温度控制功能的更精确的即时PCR仪器。这些仪器能够高精度地精确测量 DNA 熔解曲线，甚至可以检测 DNA 序列中最细微的差异。聚合酵素连锁反应热迴圈仪的改进可以更好地控制温度变化。这对于创建可重复的、高解析度的熔解曲线来区分密切相关的遗传变异至关重要。

专为 HRM 设计的嵌入染料的引入也提高了该技术的准确性和性能。用于 DNA 扩增的传统萤光染料（例如 SYBR Green）检测微小序列变异的能力有限。 LCGreen 和 EvaGreen 等新型染料能够更选择性地与双链DNA 结合，并产生更稳定的萤光讯号，更容易辨别与微小基因变化相关的解链温度变化。这些染料提高了 HRM 的灵敏度，可以更清楚地检测杂合突变、SNP 和甲基化差异。

HRM 分析软体的进步进一步优化了复杂熔化曲线的解释。现代 HRM 软体旨在更准确地分析熔解曲线，使研究人员可以透过将实验资料与已知的参考曲线进行比较来检测和量化微小的遗传差异。这些演算法可以自动同时分析多个熔解曲线、辨识模式，甚至在实验过程中提供即时回馈。机器学习和人工智慧主导的分析工具的整合将增强 HRM 识别遗传资料细微差别的能力，增加对结果的信心，并使该技术对临床和研究应用更加用户友好。

此外，多重功能允许在单一反应中同时分析多个位点或样本，从而提高了 HRM 的效用。借助优化的引子设计和染料选择，HRM 现在可用于在单次运行中区分多个靶标，从而提高通量并降低成本。这项进展在临床诊断中特别有用，其中快速检测患者样本中的多种突变和遗传标记对于诊断疾病、监测治疗反应和识别抗药性病原体至关重要。多重HRM也提高了基因筛检计划的效率，允许以时间和成本效益高的方式分析大量人口的特定遗传变异。

随着 HRM 与次世代定序(NGS) 技术的日益集成，HRM 在基因组学研究中的作用正在扩大。儘管 HRM 是一种快速且经济高效的筛检工具，但它越来越多地与 NGS 结合使用，用于在定序前对样品进行确认和预筛检。 HRM 可以快速识别具有已知突变或变异的样本，从而减少对全基因组进行大规模定序的需求。这种方法简化了遗传分析过程，节省了研究和临床应用的时间和资源。 HRM 在大规模遗传研究中特别有用，研究人员需要快速识别候选样本以进行更详细的定序。

此外，HRM 在甲基化分析方面的应用也得到了改进，这对于表观遗传学研究至关重要。 DNA甲基化在基因调控中发挥重要作用，并与包括癌症在内的多种疾病有关。甲基化敏感HRM (MS-HRM) 可以透过利用解链行为的差异来区分甲基化和非甲基化DNA 区域，使其成为表观遗传分析的快速方法，提供了一种独特的非基于序列的方法。因此，HRM 已成为了解表观遗传修饰在基因表现和疾病发展中的作用的重要工具，特别是在肿瘤学中。

为什么高解析度熔解分析对于现代分子诊断和研究至关重要？

高解析度熔解分析是现代分子诊断中的一项新兴技术，因为它提供了一种快速、准确且经济有效的检测遗传变异的方法，这对于了解疾病、抗药性和遗传疾病至关重要，并且对于研究极为重要。在临床诊断中，HRM 用于识别与囊肿纤维化、镰状性贫血和地中海贫血等遗传性疾病相关的基因突变。可以检测单核苷酸多态性（SNP）和其他细微的遗传变化，使其成为筛检患者致病突变和识别遗传性疾病携带者的理想目标。这在产前和新生儿筛检中尤其重要，早期发现遗传异常可以指南医疗干预并改善患者的治疗结果。

HRM 的重要性延伸到癌症诊断和个人化医疗，而识别 BRCA1、KRAS 和 EGFR 等癌症相关基因的特定突变对于确定最有效的治疗策略至关重要。 HRM 可以快速检测已知和新的突变，这些突变会影响癌症进展和患者对标靶治疗的反应。透过快速识别可操作的突变，HRM 支持不断发展的精准肿瘤学领域，该领域根据个体肿瘤的遗传特征量身定制治疗方案。随着时间的推移监测肿瘤突变的能力，特别是对治疗的反应，将使更个人化和适应性的癌症治疗成为可能，并改善患者的治疗结果。

在感染疾病诊断中，HRM 在检测病原体突变方面发挥着至关重要的作用，特别是在抗药性的背景下。例如，HRM 可用于检测细菌、病毒和真菌中导致抗病毒药物和抗真菌药物抗药性的基因突变。快速检测此类抗药性对于确定适当的治疗策略至关重要，特别是当抗药性导致治疗失败时。 HRM 已用于检测与抗生素抗药性结核分枝桿菌菌株、HIV 抗药性和流感变异相关的突变，从而能够及时做出明智的治疗方法决策。

HRM 在农业生物技术中也很有用，可用于遗传标记分析和植物育种计划。在作物育种中，HRM 允许研究人员透过识别与这些性状相关的遗传变异来筛检所需的性状，例如抗病性、耐旱性和产量。 HRM 在标记辅助选择中特别有用，可以帮助育种者快速识别具有优势遗传性状的植物，并加速改良作物品种的开发。此外，HRM 也用于检测基因改造作物(GMO)，透过识别与基因改造相关的特定 DNA 序列，确保作物符合监管和安全标准。

在表观遗传学领域，HRM 对于理解 DNA 甲基化模式如何影响基因表现和疾病至关重要。 DNA甲基化的变化与多种疾病有关，包括癌症、自体免疫疾病和神经系统疾病。 HRM 可以快速有效地分析甲基化模式，使其成为研究疾病进展和治疗反应中表观遗传学变化的重要工具。例如，在癌症研究中，HRM 用于检测抑癌基因的高甲基化。这可能导致通常阻止不受控制的细胞生长的基因定序。

HRM 可以快速筛检大量人群的遗传变异，使其成为群体遗传学和流行病学研究的宝贵工具。透过识别人群中的 SNP 和其他遗传标记，研究人员可以更好地了解疾病的遗传基础、追踪遗传性状的传播或监测病原体的进化。 HRM 的高通量能力和相对较低的成本使其特别适合大规模遗传研究，其中资料分析和解释需要快速识别遗传变异。

推动高解析度熔化分析市场成长的因素有哪些？

高解析度熔解(HRM) 分析市场的成长受到多种因素的推动，包括对快速且具有成本效益的基因检测的需求不断增长、对精准医疗的需求不断增长、分子诊断的进步以及基因组学作用的不断扩大这是由几个重要因素造成的。主要驱动因素之一是医疗保健领域对基因检测的需求不断增长，HRM 提供了一种快速、准确的方法来识别基因突变、SNP 和表观遗传学变化。随着基因检测融入常规医疗保健，特别是癌症诊断、新生儿筛检和产前检测，HRM 为临床医生和实验室提供了可扩展且负担得起的解决方案。

全球向个人化医疗的转变也是人力资源管理市场的主要驱动力。特别是在肿瘤学领域，随着越来越多的治疗方法根据患者的基因组成量身定制，对能够快速、准确地检测基因突变的工具的需求不断增长。 HRM 非常适合满足这一需求，因为它允许临床医生快速识别可操作的突变，从而为治疗决策提供资讯、监测治疗反应并追踪抗药性的出现。 HRM 即时快速分析遗传资料的能力是个人化医疗保健的重要工具，及时介入对于患者的治疗结果至关重要。

PCR 仪器、染料和分析软体的技术进步进一步提高了 HRM 的效用，并使包括小型实验室和诊所在内的广大用户更容易使用它。更灵敏的嵌入染料、更好的聚合酵素连锁反应热迴圈仪和改进的资料分析软体的开发提高了 HRM 的准确性和分辨率，使其成为与定序等昂贵且费力的技术相比的竞争者。这些创新使 HRM 成为从临床诊断到农业研究等广泛应用的实用选择，并且越来越多地在各个领域中被采用。

遗传和表观遗传研究在理解复杂疾病方面日益重要，也刺激了对人力资源管理的需求。研究人员越来越多地使用 HRM 来研究导致癌症、心血管疾病和神经系统疾病等疾病的基因突变、表观遗传修饰和基因表现模式。 HRM 提供了一种高通量、经济高效的方法来筛检大量样本，使其成为需要分析大量遗传标记的研究的理想选择。随着基因组学和表观遗传学研究的不断扩展，HRM 将继续成为阐明健康和疾病分子机制的宝贵工具。

在病原体检测和抗药性监测中增加HRM的使用也是推动市场成长的关键因素。由于全球卫生界面临抗生素抗药性、新出现的病毒威胁以及对快速诊断工具的需求等挑战，HRM 是检测与抗药性相关的病原体进化和突变的可靠且有效的方法。 HRM 能够快速识别导致抗药性的基因突变，使医疗保健提供者能够就治疗策略做出更明智的决策，减少抗药性菌株的传播，并改善患者的治疗效果。

最后，与次世代定序(NGS) 等复杂技术相比，HRM 价格实惠且易于使用，这使其成为临床和研究实验室的有吸引力的选择。 HRM 为预先筛检检体和确认其他基因检测方法所获得的结果提供了一种经济高效的解决方案，使其成为 NGS 和其他高通量技术的宝贵补充。这种经济性与高灵敏度和准确性的结合使其在世界各地的实验室中得到采用，特别是在快速週转和成本控制至关重要的地方。

由于分子诊断的进步、个人化医疗需求的增加以及遗传和表观遗传研究在医疗保健中作用的扩大，高分辨率熔解分析市场有望显着增长。随着基因组学不断革新医学，HRM 将继续成为快速且准确地检测遗传变异、指导治疗决策和推进疾病分子基础研究的重要工具。

受访企业范例（共12家）

  • Agilent Technologies, Inc.
  • Azura Genomics Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Canon Biomedical Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Meridian Bioscience, Inc.
  • Premier Biosoft International
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP12402

Global High-Resolution Melting Analysis Market to Reach US$419.2 Million by 2030

The global market for High-Resolution Melting Analysis estimated at US$343.8 Million in the year 2023, is expected to reach US$419.2 Million by 2030, growing at a CAGR of 2.9% over the analysis period 2023-2030. Other Applications, one of the segments analyzed in the report, is expected to record a 1.4% CAGR and reach US$31.1 Million by the end of the analysis period. Growth in the Epigenetics Application segment is estimated at 1.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$92.5 Million While China is Forecast to Grow at 2.7% CAGR

The High-Resolution Melting Analysis market in the U.S. is estimated at US$92.5 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$67.1 Million by the year 2030 trailing a CAGR of 2.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.7% and 2.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.2% CAGR.

Global High-Resolution Melting Analysis Market - Key Trends and Drivers Summarized

Is High-Resolution Melting Analysis (HRM) the Key to Rapid and Accurate Genomic Profiling in Modern Molecular Diagnostics?

High-Resolution Melting (HRM) analysis is revolutionizing molecular diagnostics and genetic research, but why is this method so crucial in modern laboratories? HRM is a post-PCR (Polymerase Chain Reaction) analysis technique used to identify genetic variations, such as single nucleotide polymorphisms (SNPs), mutations, or methylation differences in DNA. By monitoring the precise melting behavior of double-stranded DNA as it dissociates into single strands, HRM provides a rapid, high-throughput method for detecting subtle changes in DNA sequences. It is widely used in medical diagnostics, genetic research, epigenetic studies, and pathogen detection, offering a cost-effective, accurate, and efficient alternative to more labor-intensive sequencing methods.

The appeal of HRM lies in its ability to provide detailed genomic information with minimal setup and cost. HRM is fast, scalable, and can be automated, making it ideal for applications where rapid results are essential, such as in clinical settings, cancer research, and agricultural biotechnology. HRM’s sensitivity in detecting even minor genetic variations makes it a powerful tool for identifying disease-causing mutations, monitoring drug resistance, and validating genetic markers. As genomic research and precision medicine continue to expand, HRM is playing an increasingly pivotal role in advancing molecular diagnostics and personalized healthcare.

How Has Technology Advanced High-Resolution Melting Analysis?

Technological advancements have significantly improved the sensitivity, accuracy, and efficiency of High-Resolution Melting analysis, making it a more accessible and powerful tool for genetic and diagnostic applications. One of the key advancements has been in the development of more precise real-time PCR machines equipped with high-resolution optics and temperature control. These machines can accurately measure the melting curves of DNA with high precision, allowing for the detection of even the most subtle differences in DNA sequences. Improvements in thermal cyclers have enabled finer control over temperature changes, which is critical for generating reproducible and high-resolution melting profiles that differentiate between closely related genetic variants.

The introduction of intercalating dyes specifically designed for HRM has also enhanced the accuracy and performance of the technique. Traditional fluorescent dyes, such as SYBR Green, used in DNA amplification had limitations in detecting minor sequence variations. Newer dyes, like LCGreen and EvaGreen, bind more selectively to double-stranded DNA and produce more consistent fluorescence signals, enabling better discrimination of melting temperature shifts associated with small genetic changes. These dyes improve the sensitivity of HRM, making it possible to detect heterozygous mutations, SNPs, and methylation differences with greater clarity.

Advances in software for HRM analysis have further optimized the interpretation of complex melting profiles. Modern HRM software is designed to analyze melting curves with greater precision, allowing researchers to detect and quantify small genetic differences by comparing experimental data against known reference curves. These algorithms can automatically analyze multiple melting curves simultaneously, identify patterns, and even provide real-time feedback during an experiment. The integration of machine learning and AI-driven analysis tools has enhanced the ability of HRM to identify subtle variations in genetic data, improving the reliability of results and making the technique more user-friendly for both clinical and research applications.

Multiplexing capabilities have also improved the utility of HRM by enabling the simultaneous analysis of multiple genetic loci or samples in a single reaction. With the help of optimized primer design and dye selection, HRM can now be used to differentiate between multiple targets in a single run, increasing throughput and reducing costs. This advancement is particularly valuable in clinical diagnostics, where rapid detection of multiple mutations or genetic markers in a patient sample is critical for diagnosing diseases, monitoring treatment responses, or identifying drug-resistant pathogens. Multiplexed HRM also improves efficiency in genetic screening programs, where large populations can be analyzed for specific genetic variations in a time- and cost-efficient manner.

The growing integration of HRM with next-generation sequencing (NGS) technologies has expanded its role in genomics research. While HRM offers a rapid and cost-effective screening tool, it is increasingly used in conjunction with NGS to confirm or pre-screen samples before sequencing. HRM can quickly identify samples with known mutations or variations, reducing the need for extensive sequencing of entire genomes. This approach streamlines the genetic analysis process, saving time and resources in both research and clinical applications. HRM is particularly useful in large-scale genetic studies, where researchers need to quickly identify candidate samples for more in-depth sequencing.

Moreover, HRM has seen improvements in its application for methylation analysis, which is crucial for epigenetic studies. DNA methylation plays a significant role in gene regulation and has been implicated in various diseases, including cancer. Methylation-sensitive HRM (MS-HRM) allows researchers to differentiate between methylated and unmethylated DNA regions by exploiting differences in melting behavior, providing a rapid, non-sequencing-based method for epigenetic analysis. This makes HRM an essential tool for understanding the role of epigenetic modifications in gene expression and disease development, particularly in oncology.

Why Is High-Resolution Melting Analysis Critical for Modern Molecular Diagnostics and Research?

High-Resolution Melting analysis is critical for modern molecular diagnostics and research because it offers a rapid, accurate, and cost-effective method for detecting genetic variations, which are often the key to understanding diseases, drug resistance, and genetic disorders. In clinical diagnostics, HRM is used to identify mutations in genes associated with inherited diseases, such as cystic fibrosis, sickle cell anemia, and thalassemia. Its ability to detect single nucleotide polymorphisms (SNPs) and other minor genetic changes makes it ideal for screening patients for disease-causing mutations or identifying carriers of genetic disorders. This is particularly important in prenatal and newborn screening, where early detection of genetic abnormalities can guide medical interventions and improve patient outcomes.

HRM’s importance extends to cancer diagnostics and personalized medicine, where identifying specific mutations in cancer-related genes, such as BRCA1, KRAS, or EGFR, is crucial for determining the most effective treatment strategy. HRM is capable of rapidly detecting both known and novel mutations that can influence cancer progression or a patient’s response to targeted therapies. By enabling the quick identification of actionable mutations, HRM supports the growing field of precision oncology, where treatments are tailored to the genetic profile of an individual’s tumor. The ability to monitor tumor mutations over time, particularly in response to treatment, allows for more personalized and adaptive cancer care, improving outcomes for patients.

In infectious disease diagnostics, HRM plays a pivotal role in detecting pathogen mutations, particularly in the context of drug resistance. For example, HRM can be used to detect mutations in the genes of bacteria, viruses, or fungi that confer resistance to antibiotics, antivirals, or antifungal agents. This rapid detection of drug resistance is crucial in guiding appropriate treatment decisions, particularly in cases where resistance can lead to treatment failure. HRM has been used to detect mutations associated with antibiotic-resistant tuberculosis strains, HIV drug resistance, and influenza variants, enabling timely and informed decisions on treatment options.

HRM is also valuable in agricultural biotechnology, where it is used for genetic marker analysis and plant breeding programs. In crop improvement, HRM allows researchers to screen for desirable traits, such as disease resistance, drought tolerance, or higher yield potential, by identifying genetic variations linked to these traits. HRM is particularly useful in marker-assisted selection, where it helps breeders quickly identify plants with favorable genetic traits, accelerating the development of improved crop varieties. In addition, HRM is used to detect genetically modified organisms (GMOs) by identifying specific DNA sequences associated with genetic modifications, ensuring that crops meet regulatory and safety standards.

In the field of epigenetics, HRM is critical for understanding how DNA methylation patterns influence gene expression and disease. Changes in DNA methylation are associated with various diseases, including cancer, autoimmune disorders, and neurological conditions. HRM provides a rapid and efficient method for analyzing methylation patterns, making it an important tool for studying epigenetic changes in disease progression and response to therapy. In cancer research, for example, HRM is used to detect hypermethylation of tumor suppressor genes, which can lead to the silencing of genes that normally prevent uncontrolled cell growth.

The ability of HRM to quickly screen large populations for genetic variations makes it a valuable tool in population genetics and epidemiological studies. By identifying SNPs or other genetic markers across populations, researchers can better understand the genetic basis of diseases, track the spread of genetic traits, or monitor the evolution of pathogens. HRM’s high-throughput capability and relatively low cost make it particularly well-suited for large-scale genetic studies, where the rapid identification of genetic variations is necessary for data analysis and interpretation.

What Factors Are Driving the Growth of the High-Resolution Melting Analysis Market?

The growth of the High-Resolution Melting (HRM) analysis market is driven by several key factors, including the increasing demand for rapid and cost-effective genetic testing, the growing need for precision medicine, advancements in molecular diagnostics, and the expanding role of genomics in disease research. One of the primary drivers is the rising demand for genetic testing in healthcare, where HRM provides a fast and accurate method for identifying genetic mutations, SNPs, and epigenetic changes. As genetic testing becomes more integrated into routine healthcare, particularly in cancer diagnostics, newborn screening, and prenatal testing, HRM offers a scalable and affordable solution for clinicians and laboratories.

The global shift toward personalized medicine is also a major driver of the HRM market. As more therapies, especially in oncology, are tailored to the genetic makeup of patients, the need for tools that can rapidly and accurately detect genetic mutations is increasing. HRM is well-positioned to meet this demand because it allows clinicians to quickly identify actionable mutations that inform treatment decisions, monitor treatment response, and track the emergence of drug resistance. The ability to rapidly analyze genetic data in real time makes HRM an essential tool in personalized healthcare, where timely intervention is critical for patient outcomes.

Technological advancements in PCR instruments, dyes, and analytical software have further enhanced the utility of HRM, making it more accessible to a broader range of users, including smaller laboratories and clinics. The development of more sensitive intercalating dyes, better thermal cyclers, and improved data analysis software has increased the accuracy and resolution of HRM, allowing it to compete with more expensive and labor-intensive techniques like sequencing. These innovations have made HRM a practical choice for a wide range of applications, from clinical diagnostics to agricultural research, driving its adoption across multiple sectors.

The growing importance of genetic and epigenetic research in understanding complex diseases is also fueling the demand for HRM. Researchers are increasingly using HRM to study genetic variations, epigenetic modifications, and gene expression patterns that contribute to diseases such as cancer, cardiovascular conditions, and neurological disorders. HRM provides a high-throughput, cost-effective method for screening large numbers of samples, making it ideal for research studies that require the analysis of many genetic markers. As research in genomics and epigenetics continues to expand, HRM will remain a valuable tool for uncovering the molecular mechanisms underlying health and disease.

The increasing use of HRM in pathogen detection and monitoring drug resistance is another key factor driving market growth. As the global health community faces challenges such as antibiotic resistance, emerging viral threats, and the need for rapid diagnostic tools, HRM offers a reliable and efficient method for detecting mutations associated with pathogen evolution and resistance. HRM’s ability to quickly identify mutations in genes responsible for drug resistance enables healthcare providers to make more informed decisions about treatment strategies, reducing the spread of resistant strains and improving patient outcomes.

Lastly, the affordability and ease of use of HRM compared to more complex techniques like next-generation sequencing (NGS) have made it an attractive option for both clinical and research laboratories. HRM offers a cost-effective solution for pre-screening samples or confirming results obtained from other genetic testing methods, making it a valuable complement to NGS and other high-throughput technologies. This affordability, combined with its high sensitivity and accuracy, is driving its adoption in laboratories worldwide, particularly in settings where rapid turnaround and cost control are critical.

With advancements in molecular diagnostics, the growing demand for personalized medicine, and the expanding role of genetic and epigenetic research in healthcare, the High-Resolution Melting analysis market is poised for significant growth. As genomics continues to revolutionize medical science, HRM will remain an essential tool for quickly and accurately detecting genetic variations, guiding treatment decisions, and advancing research into the molecular basis of disease.

Select Competitors (Total 12 Featured) -

  • Agilent Technologies, Inc.
  • Azura Genomics Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Canon Biomedical Inc.
  • F. Hoffmann-La Roche AG
  • Illumina, Inc.
  • Meridian Bioscience, Inc.
  • Premier Biosoft International
  • Qiagen NV
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • High-Resolution Melting Analysis - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growth in Oncology and Genetic Testing Expands Addressable Market for High-Resolution Melting Analysis
    • Role of High-Resolution Melting Analysis in Enhancing Genotyping Accuracy and Speed Strengthens Business Case
    • Growth in Use of HRM Analysis in Infectious Disease Diagnostics Expands Market Opportunities
    • Expansion of High-Resolution Melting Analysis in Pharmacogenomics Drives Market Growth
    • Role of HRM in Supporting Clinical Trials and Drug Development Expands Addressable Market
    • Increasing Focus on Non-invasive Prenatal Testing (NIPT) Expands Adoption of High-Resolution Melting Analysis
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World High-Resolution Melting Analysis Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for High-Resolution Melting Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for High-Resolution Melting Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for SNP Genotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for SNP Genotyping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for SNP Genotyping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Mutation Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Mutation Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Mutation Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Species Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Species Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Species Identification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pathogen Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pathogen Identification by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Pathogen Identification by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Epigenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Epigenetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Reagents & Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Reagents & Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: World 16-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Software & Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: World 16-Year Perspective for Software & Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: USA 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: USA 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Canada 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Canada 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • JAPAN
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: Japan 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Japan 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • CHINA
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: China Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: China 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: China Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: China 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • EUROPE
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for High-Resolution Melting Analysis by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for High-Resolution Melting Analysis by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: Europe 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Europe 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • FRANCE
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: France Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: France 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: France Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: France 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • GERMANY
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Germany 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Germany 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: Italy 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Italy 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: UK 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: UK 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • High-Resolution Melting Analysis Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 101: Rest of World Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Rest of World Historic Review for High-Resolution Melting Analysis by Application - SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Rest of World 16-Year Perspective for High-Resolution Melting Analysis by Application - Percentage Breakdown of Value Sales for SNP Genotyping, Mutation Discovery, Species Identification, Pathogen Identification, Epigenetics and Other Applications for the Years 2014, 2024 & 2030
    • TABLE 104: Rest of World Recent Past, Current & Future Analysis for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Rest of World Historic Review for High-Resolution Melting Analysis by Products & Services - Reagents & Consumables, Instruments and Software & Services Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Rest of World 16-Year Perspective for High-Resolution Melting Analysis by Products & Services - Percentage Breakdown of Value Sales for Reagents & Consumables, Instruments and Software & Services for the Years 2014, 2024 & 2030

IV. COMPETITION